Equity Components [Axis] Common Stock [Member] Additional Paid-in Capital [Member] Retained Earnings [Member] AOCI Attributable to Parent [Member] Cash and Cash Equivalents [Axis] US Treasury Securities [Member] Long-Lived Asset, Class [Axis] Building [Member] Antidilutive Securities [Axis] Share-Based Payment Arrangement, Option [Member] Warrant [Member] Restricted Stock Units (RSUs) [Member] Financial Instrument [Axis] Sale of Stock [Axis] IPO [Member] Over-Allotment Option [Member] July 2024 Firm Commitment Public Offering [Member] July 2024 Follow On Overallotment Warrants [Member] July 2024 Follow on Overallotment Warrant [Member] Title and Position [Axis] Lead Managing Underwriter [Member] October 2024 Follow On Offering [Member] October 2024 Follow On Over Allotment Option [Member] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Securities Purchase Agreement [Member] Private Placement [Member] May 2025 Private Placement [Member] May 2025 Placement Agency Agreement [Member] 2025 ATM Agreement [Member] Statistical Measurement [Axis] Maximum [Member] Plan Name [Axis] 2025 Equity Incentive Plan [Member] Award Type [Axis] 2023 Stock Option Plan [Member] 2023 Stock Option Plans [Member] Minimum [Member] Common Stock One [Member] Common Stock Two [Member] Award Date [Axis] One Third Grant Date Anniversary [Member] Grant Date Anniversary [Member] Six Month Grant Date Anniversary [Member] 2025 Equity Plan [Member] Land, Buildings and Improvements [Member] Legal Entity [Axis] Nuclear Technology Headquaters [Member] KRONOSMMR Microreactor Energy System [Member] Land [Member] Asset Acquisition [Axis] ALIP Technology [Member] Dr Maidana [Member] Investment, Name [Axis] LIS Technologies Inc [Member] Subsequent Event Type [Axis] Subsequent Event [Member] Business Combination [Axis] Canadian Consents [Member] Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Statement of Financial Position [Abstract] ASSETS Current assets: Cash and cash equivalents Short-term investments Accounts receivable, net Prepaid expenses Deposits, current Marketable securities, at fair value Total current assets Deferred offering costs Deposits, non-current Property, plant and equipment, net Right-of-use assets Long-term investments, related party In-process research and development Total assets LIABILITIES AND STOCKHOLDERS’ EQUITY Current liabilities: Accounts payable and accrued liabilities Lease liabilities, current Contingent consideration Total current liabilities Lease liabilities, non-current Total liabilities Stockholders’ equity Preferred stock, $0.0001 par value; 25,000,000 authorized as of March 31, 2026 and September 30, 2025; none issued and outstanding as of March 31, 2026 and September 30, 2025 Common stock, $0.0001 par value; 275,000,000 authorized as of March 31, 2026 and September 30, 2025; 52,083,294  and 41,738,358 shares issued and outstanding as of March 31, 2026 and September 30, 2025, respectively Additional paid-in capital Accumulated deficit Accumulated other comprehensive loss Total stockholders’ equity Total liabilities and stockholders’ equity Preferred stock, par value Preferred stock, shares authorized Preferred stock, shares issued Preferred stock, shares outstanding Common stock, par value Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Income Statement [Abstract] Operating expenses General and administrative Research and development Change in fair value of contingent consideration Loss from operations Other income Unrealized loss on marketable securities Gain on settlement of accounts receivable Net loss Other comprehensive income (loss): Cumulative translation adjustment Comprehensive loss Net loss per share of common stock: Basic Diluted Weighted-average shares of common stock outstanding: Basic Diluted Statement [Table] Statement [Line Items] Balance Balance, shares Exercise of warrants Exercise of warrants, shares Exercise of stock options Exercise of stock options, shares Equity-based compensation Equity-based compensation, shares Net loss Accumulated other comprehensive income (loss) Common stock issuances Common stock issuances, shares Offering costs Balance Balance, shares Statement of Cash Flows [Abstract] OPERATING ACTIVITIES Adjustments to reconcile net loss to net cash used in operating activities: Equity-based compensation Amortization of right-of-use assets Depreciation Changes in fair value of contingent liability Bank revaluation Unrealized loss on marketable securities Non-cash interest income on short-term investments Gain on settlement of accounts receivable Change in assets and liabilities: Prepaid expenses Deposits Accounts payable and accrued liabilities Due to related parties Lease liabilities Net cash used in operating activities INVESTING ACTIVITIES Purchase of short-term investments Additions to property, plant and equipment Deposits In-process research and development Net cash used in investing activities FINANCING ACTIVITIES Proceeds from common stock issuances Offering costs Proceeds from exercise of warrants Proceeds from exercise of stock options Payment of deferred offering costs Net cash provided by financing activities Net increase (decrease) in cash and cash equivalents Cash and cash equivalents, beginning of period Effect of exchange rate changes on cash Cash and cash equivalents, end of period Non-cash transactions: Inception of Right-of-Use Asset / Liability Supplemental disclosures of cash flow information Cash paid for income and franchise taxes Organization, Consolidation and Presentation of Financial Statements [Abstract] ORGANIZATION AND OPERATIONS AND BASIS OF PRESENTATION Accounting Policies [Abstract] SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Cash and Cash Equivalents [Abstract] SHORT-TERM INVESTMENTS Other Income and Expenses [Abstract] OTHER INCOME Equity [Abstract] EQUITY Property, Plant, and Equipment [Abstract] PROPERTY, PLANT AND EQUIPMENT Right-of-use Assets And Lease Liabilities RIGHT-OF-USE ASSETS AND LEASE LIABILITIES Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation [Abstract] ACQUISITION OF ALIP TECHNOLOGY Investments, All Other Investments [Abstract] LONG-TERM INVESTMENTS, RELATED PARTY Usnc Asset Acquisition USNC ASSET ACQUISITION Subsequent Events [Abstract] SUBSEQUENT EVENTS Basis of Presentation Cash Equivalents Short-term Investments Use of Estimates Fair Value Measurement Concentration of Credit Risk Accounts Receivable Prepaid Expenses Property, Plant and Equipment In-process Research and Development Depreciation Leases Warrant Instruments Investments in Equity – Related Party Equity-Based Compensation Research and Development Advertising Costs Legal Contingencies Income Taxes Net Loss per Share Operating Segments Recent Accounting Pronouncements SCHEDULE OF STRAIGHT LINE METHOD BASED ON ESTIMATED USEFUL LIVES SCHEDULE OF SHARES EXCLUDED FROM DILUTED PER SHARE AMOUNT SCHEDULE OF FAIR VALUE OF SHORT TERM INVESTMENTS SCHEDULE OF CUMULATIVE OPTION ACTIVITY SCHEDULE OF RESTRICTED STOCK UNIT ACTIVITY SCHEDULE OF CUMULATIVE WARRANT ACTIVITY SCHEDULE OF PROPERTY, PLANT AND EQUIPMENT SCHEDULE OF RIGHT OF USE ASSET AND LEASE LIABILITIES SCHEDULE OF BALANCE SHEET INFORMATION SCHEDULE OF LEASE EXPENSE SCHEDULE OF OTHER INFORMATION RELATED TO LEASES SCHEDULE OF EXPECTED ANNUAL MINIMUM LEASE PAYMENTS SCHEDULE OF ALIP ACQUISITION SCHEDULE OF ALLOCATION OF CONSIDERATION Working capital Accumulated deficit Net income (loss) Cash flows from operations Proceeds from exercises of warrants Proceeds from exercises of stock options Net proceeds from private placement offering Property, Plant, and Equipment [Table] Property, Plant, and Equipment [Line Items] Property, Plant, and Equipment, Useful Life, Term, Description [Extensible Enumeration] Estimated useful life Antidilutive Security, Excluded EPS Calculation [Table] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Total shares excluded Cash and Cash Equivalent [Table] Cash and Cash Equivalents [Line Items] Investments in equity Impairment on investments in equity Advertising costs Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Table] Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items] Amortized cost Allowance for Credit Losses Net Carrying Amount Gross Unrealized Losses Fair Value Short term investment Fair value of short term investment Interest income on cash and cash equivalents Interest income from consulting services Interest earned from lease agreement Number of shares, outstanding, beginning Weighted average exercise price per share, outstanding, beginning Weighted average contractual term, outstanding Aggregate intrinsic value, outstanding, beginning Number of shares, granted Weighted average exercise price per share, granted Aggregate intrinsic value, granted Number of shares, forfeited Weighted average exercise price per share, forfeited Aggregate intrinsic value, forfeited Number of shares, exercised Weighted average exercise price per share, exercised Aggregate intrinsic value, exercised Number of shares, expired Weighted average exercise price per share, exercised Aggregate intrinsic value, exercised Number of shares, outstanding, ending Weighted average exercise price per share, outstanding, ending Aggregate intrinsic value, outstanding, ending Number of shares, outstanding , Exercisable at the end of period Weighted average exercise price per share, Exercisable at the end of period Weighted average contractual term, Exercisable at the end of period Aggregate intrinsic value, Exercisable at the end of period Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Number of shares, outstanding, beginning Weighted- average grant date fair value per share, outstanding beginning Aggregate intrinsic value, outstanding, beginning Number of shares, granted Weighted- average grant date fair value per share, granted Aggregate intrinsic value, granted Number of shares, vested Weighted- average grant date fair value per share, vested Aggregate intrinsic value, granted Number of shares, outstanding, ending Weighted- average grant date fair value per share, outstanding ending Aggregate intrinsic value, outstanding, ending Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Line Items] Number of warrant shares, outstanding, beginning Weighted average exercise price per share, outstanding, beginning Weighted average contractual term (in years), outstanding Number of shares warrants issued Weighted average exercise price per share, issued Weighted average contractual term (in years), outstanding, warrant issued Number of shares warrants exercised Weighted average exercise price per share, exercised Number of warrant shares, outstanding, Ending Weighted average exercise price per share, outstanding, ending Subsidiary or Equity Method Investee, Sale of Stock, Type [Table] Subsidiary, Sale of Stock [Line Items] Common stock, shares outstanding Issuance of shares Price per share Proceeds from issuance initial public offering Net proceeds Purchase of warrants Exercise price Additional paid in capital issuance costs Warrants to purchase shares Warrant issued Market price per share Gross proceeds from issuance of common stock Net proceeds from issuance of common stock Purchase of common stock Stock issuance costs Warrants exercised Warrant expiry Proceds from private placement Warrants term Cash fee percentage Non accountable expense allowance percentage Legal expenses Sale of common stock Sale of stock offering price Common stock , par value Proceds from private placement , gross Common stock available for issuance Share based compensation description Common stock available for issuance Shares stock option exercised Exercise prices Cash proceeds Number of shares issued Exercise price Expiry date Shares vested stock option Vested stock option Stock compensation expense Weighted average period Restricted stock units, granted Restricted stock units, fair value Restricted stock units, one-third vested Restricted stock units, percent Unvested RSUs Weighted average grant-date fair value RSU unrecognized compensation RSU weighted-average period Beginning of period Additions – land Additions – building Additions – leasehold improvements Additions – construction in progress End of period Accumulated depreciation Beginning of period Depreciation of building Depreciation of leasehold improvements End of period Total property, plant and equipment, net Area of land Money spend on acquisition of land Schedule Of Right Of Use Asset And Lease Liabilities Right-of-use assets Beginning of period Additions Amortization End of period Schedule Of Balance Sheet Information Operating right-of-use assets Operating lease liabilities, current Operating lease liabilities, long term Operating lease cost Operating cash outflows from operating leases Weighted-average discount rate - operating lease Weighted-average remaining lease term - operating lease (in years) 2026 2027 2028 2029 Thereafter Total future minimum lease payments, undiscounted Less: Imputed interest for leases in excess of one year Present value of future minimum lease payments Less: Current portion of lease liabilities Total lease liabilities, less current portion Asset Acquisition [Table] Asset Acquisition [Line Items] Total purchase price Cash (paid on closing) Shares of Common Stock (issued on closing) Contingent cash Contingent Common Stock (fair value at closing) Number of shares issued for acquisitions Cash consideration Contingent consideration Revaluation expense InvestmentsAllOtherInvestmentsTable [Table] Equity method investment Investment Lease payment Restructuring Cost [Table] Restructuring Cost and Reserve [Line Items] Cash consideration paid Less: Value of Consent Assets (subject to Canadian Consents) held in escrow Add: Assumed liabilities related to Designated Contracts (excluding Canadian Contracts) Total fair value of Acquired IPR&D Assets Subsequent Event [Table] Subsequent Event [Line Items] Escrow deposit Held in escrow Reimbursement allowance Expect to pay assumed liability Escrow amount Value of warrants exercised. Shares of warrants exercised. Bank revaluation. Noncash interest income on shortterm investments Payments for research and development expense Payment of deferred offering costs. Inception of Right of use asset lease liability. Working capital. Short Term Investments [Policy Text Block] Prepaid Expenses [Policy Text Block] Schedule Of Property Plant And Equipments Estimated Useful Lives [Table Text Block] Warrant Instruments [Policy Text Block] July 2024 Firm Commitment Public Offering [Member] Issuance of common stock. Purchase of common stock. July 2024 Follow On Overallotment Warrants [Member] July 2024 Follow on Overallotment Warrant [Member] Lead Managing Underwriter [Member] October 2024 Follow On Offering [Member] Warrants exercised. October 2024 Follow On Over Allotment Option [Member] Securities Purchase Agreement [Member] Cash fee percentage. Non accountable expense allowance percentage. May 2025 Private Placement [Member] May 2025 Placement Agency Agreement [Member] 2025 ATM Agreement [Member] Proceeds from issuance of private placement gross. 2025 Equity Incentive Plan [Member] 2023 Stock Option Plan [Member] 2023 Stock Option Plans [Member] Common Stock One [Member] Common Stock Two [Member] Stock issued during period shares stock options expired Share based compensation arrangements by share based payment award options expiration in period weighted average exercise price Aggregate intrinsic value, options granted. Share based compensation arrangement by share based payment award options forfeited in period total intrinsic value. Share based compensation arrangement by share based payment award options expired in period total intrinsic value One Third Grant Date Anniversary [Member] Grant Date Anniversary [Member] Six Month Grant Date Anniversary [Member] Share based compensation arrangement by share based payment award options vested percentage. 2025 Equity Plan [Member] Share based compensation arrangement by share based payment award equity instruments other than options aggregate intrinsic value granted. Weighted average exercise price per share, outstanding. Weighted average exercise price per share, warrants issued. Share based compensation arrangement by share based payment award equity instruments other than options outstanding weighted average remaining contractual terms granted. Weighted average exercise price per share, warrants exercised. Additions – land. Additions – building. Property plant and equipment additions on leasehold improvements. Property plant and equipment additions on construction in progress. Depreciation of leasehold improvements Nuclear Technology Headquaters [Member] KRONOSMMR Microreactor Energy System [Member] Right Of Use Asset And Lease Liabilities Disclosure [Text Block] Schedule Of Right Of Use Asset And Lease Liabilities [Table Text Block] Right Of Use Asset Roll Forward [Abstract] Right of use of asset additions. Accumulated depreciation. Schedule Of Balance Sheet Information [Table Text Block] Schedule Of Other Information Related To Leases [Table Text Block] Lessee operating lease liability payments due after year three. ALIP Technology [Member] Dr Maidana [Member] Asset acquisition consideration transferred contingent consideration shares. Revaluation expense. LIS Technologies Inc [Member] Usnc Asset Acquisition [Text Block] Reimbursement allowance. Canadian Consents [Member] Value of canadian assets held in escrow. Assumed liabilities related to designated contracts. Proceeds from issuance of cash Payment to acquire deposits Marketable securities at fair value. Inprocess research and development assets. Useful Life, Lease Term [Member] Assets, Current Assets Liabilities, Current Liabilities Equity, Attributable to Parent Liabilities and Equity Operating Expenses Comprehensive Income (Loss), Net of Tax, Attributable to Parent Weighted Average Number of Shares Outstanding, Basic Weighted Average Number of Shares Outstanding, Diluted Shares, Outstanding Share-Based Payment Arrangement, Noncash Expense Increase (Decrease) in Prepaid Expense Increase (Decrease) in Deposit Assets Increase (Decrease) in Accounts Payable and Accrued Liabilities Cash Provided by (Used in) Operating Activity, Including Discontinued Operation Payments to Acquire Short-Term Investments Payments to Acquire Property, Plant, and Equipment PaymentToAcquireDeposits PaymentsForResearchAndDevelopmentExpense Cash Provided by (Used in) Investing Activity, Including Discontinued Operation PaymentOfDeferredOfferingCosts Cash Provided by (Used in) Financing Activity, Including Discontinued Operation Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Excluding Exchange Rate Effect, Including Discontinued Operation Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Including Discontinued Operation Depreciation, Depletion, and Amortization [Policy Text Block] Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value StockIssuedDuringPeriodSharesStockOptionsExpired ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationInPeriodWeightedAverageExercisePrice ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpiredInPeriodTotalIntrinsicValue Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueGranted Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Vested Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisesInPeriodWeightedAverageExercisePrice Property, Plant, and Equipment, before Accumulated Depreciation, Depletion, and Amortization Property, Plant, and Equipment, Accumulated Depreciation, Depletion, and Amortization DepreciationOfLeaseholdImprovements Right Of Use Asset Roll Forward [Abstract] Lessee, Operating Lease, Liability, to be Paid Lessee, Operating Lease, Liability, Undiscounted Excess Amount Operating Lease, Liability Asset Acquisition, Contingent Consideration, Liability Business Combination, Recognized Asset Acquired, Asset